4
Changes in Ownership
Aardvark Therapeutics, Inc. Filed Acc 0000950170-25-086141
Options or other derivatives
- Director acquired 30,508 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Baynes Roy D. · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-11 | Grant or award : show line 1 in the form Stock Option (right to buy) | +30,508 | 30,508 | D |
Loading xslF345X05/ownership.xml…